157 related articles for article (PubMed ID: 29313212)
1. Hyperbaric Oxygen Attenuates Withdrawal Symptoms by Regulating Monoaminergic Neurotransmitters and NO Signaling Pathway at Nucleus Accumbens in Morphine-Dependent Rats.
Chen C; Fan Q; Nong Z; Chen W; Li Y; Huang L; Feng D; Pan X; Lan S
Neurochem Res; 2018 Mar; 43(3):531-539. PubMed ID: 29313212
[TBL] [Abstract][Full Text] [Related]
2. Yulangsan polysaccharide attenuates withdrawal symptoms and regulates the NO pathway in morphine-dependent rats.
Chen C; Nong Z; Huang J; Chen Z; Zhang S; Jiao Y; Chen X; Huang R
Neurosci Lett; 2014 Jun; 570():63-8. PubMed ID: 24747687
[TBL] [Abstract][Full Text] [Related]
3. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
4. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.
Ghosh S; Grasing K
Neurochem Res; 1999 Jan; 24(1):95-107. PubMed ID: 9973242
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
8. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons.
Bull PM; Ludwig M; Blackburn-Munro GJ; Delgado-Cohen H; Brown CH; Russell JA
Eur J Neurosci; 2003 Nov; 18(9):2545-51. PubMed ID: 14622155
[TBL] [Abstract][Full Text] [Related]
9. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.
Zhou Q; Nyberg F
Neurosci Lett; 2002 Mar; 320(3):117-20. PubMed ID: 11852176
[TBL] [Abstract][Full Text] [Related]
10. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
Schoffelmeer AN; Wardeh G; Vanderschuren LJ
Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
[TBL] [Abstract][Full Text] [Related]
11. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
12. Exogenous sodium hydrosulfide can attenuate naloxone-precipitated withdrawal syndromes and affect cAMP signaling pathway in heroin-dependent rat's nucleus accumbens.
Jiang LH; Wang J; Wei XL; Liang QY; Cheng TT
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1974-82. PubMed ID: 23242725
[TBL] [Abstract][Full Text] [Related]
13. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal Catecholamine Changes during Opiate Exposure and Withdrawal.
Fox ME; Rodeberg NT; Wightman RM
Neuropsychopharmacology; 2017 Feb; 42(3):671-681. PubMed ID: 27461081
[TBL] [Abstract][Full Text] [Related]
16. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal.
García-Pérez D; Núñez C; Laorden ML; Milanés MV
Addict Biol; 2016 Mar; 21(2):374-86. PubMed ID: 25522207
[TBL] [Abstract][Full Text] [Related]
17. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system.
Aricioglu F; Means A; Regunathan S
Eur J Pharmacol; 2004 Nov; 504(3):191-7. PubMed ID: 15541421
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone potentiates development of morphine-dependence in mice: possible role of NO/cGMP pathway.
Javadi S; Ejtemaeimehr S; Keyvanfar HR; Moghaddas P; Aminian A; Rajabzadeh A; Mani AR; Dehpour AR
Brain Res; 2013 May; 1510():22-37. PubMed ID: 23399681
[TBL] [Abstract][Full Text] [Related]
19. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
Murphy NP; Onaka T; Brown CH; Leng G
Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
[TBL] [Abstract][Full Text] [Related]
20. Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex.
Rada PV; Mark GP; Taylor KM; Hoebel BG
Pharmacol Biochem Behav; 1996 Apr; 53(4):809-16. PubMed ID: 8801582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
